NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1871818419 M.D.
Verify on CMS → Swathi Rao, M.D.
Endocrinology, Diabetes & Metabolism Physician in Noblesville, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 372 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
25%
generic claims · 65% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.5K
55 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Swathi Rao, M.D. filed 3,813 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Noblesville, Indiana, prescribing 25% generic.
- 4K
- Part D claims, 2024
- 25%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥91st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Swathi Rao, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1871818419), first enumerated 04/06/2010.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,813 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.5K in reported industry payments (55 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1871818419 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1871818419
- ENUM-MID 2010
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 3,813
- BOOK-THIN 136 in Indiana
- PHOTO-ENUM Lauren Labryer · 2010
Swathi Rao, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
3,813 ≥ 91st percentile 91% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Swathi Rao, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Swathi Rao, M.D.?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
3,813 39% vs specialty avg
Specialty distribution in Indiana
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Indiana providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1871818419 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/06/2010 |
Hospital and facility affiliations
Facilities where Swathi Rao, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Parkview Health System Inc
Fort Wayne, IN
Riverview Hospital
Noblesville, IN
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Swathi Rao, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.5K
Largest payer
Abbott Laboratories
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Swathi Rao, M.D. - brand share 65.0%
Endocrinology, Diabetes & Metabolism Physician average
65% brand-name claims vs 25% generic, on 3,813 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,813
Total Claims
$2.3M
Total Drug Cost
372
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 8,240.967
- Total Day Supply
- 243,477
- Brand vs Generic
- 65% brand / 25% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $45K
Patient Demographics
- Average Patient Age
- 71.4 years
- Avg HCC Risk Score
- 1.89
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 52, 65-74: 173, 75-84: 125, 85+: 22
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Swathi Rao, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
297 claims
- Ozempic
Ozempic
205 claims
- Lantus Solostar
Lantus Solostar
166 claims
- Jardiance
Jardiance
160 claims
- Mounjaro
Mounjaro
151 claims
- Synthroid
Synthroid
132 claims
- Metformin Hcl Er
Metformin Hcl Er
120 claims
- Unithroid 116
Unithroid
116 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 297 |
| Ozempic Semaglutide | 205 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 166 |
| Jardiance Empagliflozin | 160 |
| Mounjaro Tirzepatide | 151 |
| Synthroid Levothyroxine Sodium | 132 |
| Metformin Hcl Er Metformin Hcl | 120 |
| Unithroid Levothyroxine Sodium | 116 |
| Humalog Kwikpen U-100 Insulin Lispro | 115 |
| Tresiba Flextouch U-100 Insulin Degludec | 102 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in IN →
All providers in Indiana →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Swathi Rao, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Swathi Rao, M.D.'s 3,813 claims are above the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Rao, both outside Indiana so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2010)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Rao.
One of 136 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Indiana, 5 are shown here.
Dr. John Adlard
MD
Munster, IN
Dr. Vrinda Agrawal
M.D.
Michigan City, IN
Dr. Rebecca Aguirre
MD/PHD
Indianapolis, IN
Dr. Folake Akanbi
MD
Fort Wayne, IN
Dr. Shifa Batool Akhter
M.D.
Indianapolis, IN
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Swathi Rao, M.D.'s specialty? ▼
Swathi Rao, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Noblesville, Indiana. Credentials: M.D..
How much does Swathi Rao, M.D. prescribe under Medicare Part D? ▼
In 2024, Swathi Rao, M.D. wrote 3,813 Medicare Part D claims totaling $2.3M in drug costs for 372 beneficiaries.
Where is Swathi Rao, M.D. located? ▼
Swathi Rao, M.D. is located at 395 WESTFIELD RD STE D, Noblesville, IN, 46060. Phone: (317) 776-3520.
What is Swathi Rao, M.D.'s NPI number? ▼
Swathi Rao, M.D.'s National Provider Identifier (NPI) is 1871818419, issued on 04/06/2010.
Does Swathi Rao, M.D. prescribe more brand-name or generic drugs? ▼
Swathi Rao, M.D.'s prescribing is 65% brand-name and 25% generic drugs by claim count, with $2.1M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Swathi Rao, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Swathi Rao, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Lantus Solostar. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Swathi Rao, M.D. accept Medicare? ▼
Swathi Rao, M.D. appears in CMS Medicare data with 3,813 Part D claims and 372 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Swathi Rao, M.D.'s credentials? ▼
Swathi Rao, M.D.'s NPI is 1871818419 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.